Mary Chapman,  features writer—

Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.

Articles by Mary Chapman

Angelman Syndrome in Adults

While the first signs of Angelman syndrome usually appear in early childhood, adults with the disease can live long and full lives with appropriate treatment and a good support network. Below are some pointers about how the rare genetic disease affects adults and the therapies researchers are…

Seizure Diaries for Angelman Syndrome

About 90% of Angelman syndrome patients experience seizures, which usually first appear around the age of 2 — possibly before the disease itself has been diagnosed. Seizure diaries can help you manage, and possibly better treat, your child’s condition. What is Angelman syndrome? Angelman syndrome is a…

FAST Awards $3M to UC Davis Scientists Seeking Better AS Treatments

Supporting efforts to find effective treatments for Angelman syndrome (AS), the Foundation for Angelman Syndrome Therapeutics (FAST) has awarded two UC Davis MIND Institute scientists a $3 million grant. The recipients are Jill Silverman, PhD, associate professor in the Institute’s department of psychiatry and behavioral sciences, and…